Drug profile · INN
pseudoephedrine polistirex
PSEUDO-12
pseudoephedrine polistirex (PSEUDO-12) is a norepinephrine transporter releasing agent. Route of administration: oral. Current US regulatory status: approved.
Drug details — pseudoephedrine polistirex
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
pseudoephedrine polistirex (PSEUDO-12) is a norepinephrine transporter releasing agent. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Norepinephrine transporter releasing agent
Primary target: Sodium-dependent noradrenaline transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is pseudoephedrine polistirex?
pseudoephedrine polistirex (PSEUDO-12) is a norepinephrine transporter releasing agent. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for pseudoephedrine polistirex?
PSEUDO-12 is a marketed brand name for pseudoephedrine polistirex. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pseudoephedrine polistirex?
pseudoephedrine polistirex has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.